Verve Pauses Enrollment in Base Editing Trial after Adverse Events.

Alex Philippidis

Published in: Human gene therapy (2024)

Keyphrases

crispr cas
phase iii
study protocol

phase ii
clinical trial

health insurance
open label

affordable care act
healthcare